Literature DB >> 16246187

Inflammatory bowel disease in Iran: a review of 457 cases.

Rahim Aghazadeh1, Mohammad Reza Zali, Ali Bahari, Kamyar Amin, Farzin Ghahghaie, Farzad Firouzi.   

Abstract

BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) was believed to be infrequent in Iran; however, unofficial reports have confessed the continuing rise in IBD in our country.
METHODS: Demographic and clinical features, extraintestinal manifestations, extension of disease and complications of 401 patients with ulcerative colitis (UC), 47 with Crohn's disease (CD), and nine with indeterminatn colitis (IC) were assessed retrospectively. The exact course of physicians' visits of 250 IBD patient was asked through face-to-face interview.
RESULTS: Mean age at diagnosis was 31.9 years in UC and 30.5 years in CD patients. The male to female ratio was 0.8 for UC and 1.3 for CD. The percentage of CD and UC patients who were non-smokers was 82.9 and 84.5%, respectively. Patients with UC presented with rectal bleeding (41.9%), whereas those with CD complained of abdominal pain (46.9%). Among UC patients, proctosigmoid was affected in 51.9%. Colorectal cancer was diagnosed in two patients. The mean lag time between the onset of symptoms and definite diagnosis was 13.9 and 17.7 months for UC and CD patients, respectively. A total of 32.4% of patients with IBD had at least one of the five major extra-intestinal diseases.
CONCLUSION: The demographic and clinical picture of IBD is more or less the same as that of other developing countries; however, the rarity of CD in Iran is noted. Although the true epidemiologic profile of IBD in Iran is still unknown, it is not as rare as previously thought, and it seems as if gradual adoption of a Western lifestyle may be associated with the continuing rise in IBD. (c) 2005 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16246187     DOI: 10.1111/j.1440-1746.2005.03905.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  60 in total

1.  NOD2 exonic variations in Iranian Crohn's disease patients.

Authors:  Nosratollah Naderi; Alma Farnood; Manijeh Habibi; Homayoun Zojaji; Hedieh Balaii; Farzad Firouzi; Mohsen Chiani; Faramarz Derakhshan; Ali Tahami; Rahim Aghazadeh; Nasser Ebrahimi Daryani; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2011-01-28       Impact factor: 2.571

2.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

3.  Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement.

Authors:  Young Hwangbo; Hyo Jong Kim; Ji Seon Park; Kyung Nam Ryu; Nam Hoon Kim; Jaejun Shim; Jae Young Jang; Seok Ho Dong; Byung Ho Kim; Young Woon Chang; Rin Chang
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

4.  Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.

Authors:  Bikramjit Singh; Saurabh Kedia; Gauree Konijeti; Venigalla Pratap Mouli; Rajan Dhingra; Lalit Kurrey; Saurabh Srivastava; Rajesh Pradhan; Govind Makharia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2015-02-07

Review 5.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

6.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

7.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Jonathan S Levine; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

8.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Authors:  Maddalena Zippi; Claudia Corrado; Roberta Pica; Eleonora Veronica Avallone; Claudio Cassieri; Daniela De Nitto; Paolo Paoluzi; Piero Vernia
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 9.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

10.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.